FINERENONE (Kerendia®)

Clinical Indication

Chronic heart failure with preserved or mildly reduced ejection fraction

Comments

In line with NICE TA1182

Funding from:  3rd November 2026

Date of classification

October 2026

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.